Trellus Health plc (AIM:TRLS)

Market Cap	2.75M
Revenue (ttm)	43.52K
Net Income (ttm)	-5.27M
Shares Out	161.51M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	163,477
Average Volume	690,653
Open	1.700
Previous Close	1.700
Day's Range	1.600 - 1.700
52-Week Range	0.500 - 5.400
Beta	2.37
RSI	35.59
Earnings Date	Apr 24, 2025

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was fo...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2020
• Employees: 31
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TRLS

Financial Performance

In 2023, Trellus Health's revenue was $19,000, an increase of 5.56% compared to the previous year's $18,000. Losses were -$6.34 million, -28.05% less than in 2022.

Financial numbers in USD